Trial intelligence / Profile preview

POP: Palbociclib in Early Breast Cancer

NCT02008734Phase 2Completed

Sponsor
Gustave Roussy
Start
Jan 2014
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of palbociclib in breast cancer, sponsored by Gustave Roussy. Started Jan 2014; status: completed.

02

Drugs

palbociclib
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02008734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02008734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call